UNC startup Ribometrix pioneers new technology to target RNA, unlock new disease therapies
March 29, 2018
Today, the majority of drugs and pharmaceuticals on the market that treat human disease are designed to target a specific protein. But University of North Carolina at Chapel Hill startup Ribometrix has a very different, revolutionary approach to new drug discovery that’s proving to be a breakthrough in the industry.